You are here

  • Home
  • Archive
  • Volume 12, Issue 4
  • Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using 90Y-NM600 in combination with androgen deprivation therapy in murine prostate tumors

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using 90Y-NM600 in combination with androgen deprivation therapy in murine prostate tumors

 

Online download statistics by month:

Online download statistics by month: April 2024 to September 2025

AbstractFullPdf
Apr 2024510513125
May 2024679686239
Jun 2024221224106
Jul 2024454456432
Aug 2024868745
Sep 2024126134782
Oct 2024929246
Nov 2024939445
Dec 202410310448
Jan 202511411568
Feb 2025949453
Mar 202511212989
Apr 2025949451
May 202512612989
Jun 2025797935
Jul 2025110
Sep 2025110
Total298530322253